Journal Guide

The journal of ‘CardioRenal Medicine’ explores the mechanisms by which obesity and other metabolic abnormalities promote the pathogenesis and progression of heart and kidney disease (cardiorenal metabolic syndrome). It provides an interdisciplinary platform for the advancement of research and clinical practice, focussing on translational issues. Attention is paid to the fact that some metabolic abnormalities cluster with heart and chronic kidney disease, and collectively this is called the cardiorenal metabolic syndrome. Moreover, certain metabolic abnormalities of the heart promote impaired coronary artery endothelial function, diastolic dysfunction and ischemic reconditioning that parallel glomerular hyperfiltration and impairments in proximal tubule handling of sodium and albumin. Another point of focus is the role of the obesity epidemic in promoting the increasing incidence of heart and kidney disease in industrialized countries and the prevailing problems of insufficient exercise and excessive consumption of cheap, unwholesome food in promotion of the cardiorenal metabolic syndrome in both adults and children.

Central Nervous System Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new central nervous system agents.

Clinical Genitourinary Cancer is a peer-reviewed journal that publishes original articles describing various aspects of clinical and translational research in genitourinary cancers. Clinical Genitourinary Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of genitourinary cancers. The main emphasis is on recent scientific developments in all areas related to genitourinary malignancies. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Current Aging Science publishes frontier review and experimental articles in all areas of aging and age-related research that may influence longevity. This multidisciplinary journal will help in understanding the biology and mechanism of aging, genetics, pathogenesis, intervention of normal aging process and preventive strategies of age-related disorders. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, clinical, molecular, and animal models, including lower organism models (e.g., yeast, Caenorhabditis elegans and Drosophila). In addition to the affect of aging on integrated systems, the journal also covers original articles on recent research in fast emerging areas of adults stem cells, brain imaging, calorie restriction, immunosenescence, molecular diagnostics, pharmacology and clinical aspects of aging. Manuscripts are encouraged that relate to developmental programming of aging and the synergistic mechanism of aging with cardiovascular diseases, obesity and neurodegenerative disorders.

Current Alzheimer Research publishes peer-reviewed frontier review, research, drug clinical trial studies and letter articles on all areas of Alzheimer’s disease. This multidisciplinary journal will help in understanding the neurobiology, genetics, pathogenesis, and treatment strategies of Alzheimer’s disease. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, molecular, and animal models. The journal also covers original articles on recent research in fast emerging areas of molecular diagnostics, brain imaging, drug development and discovery, and clinical aspects of Alzheimer’s disease. Manuscripts are encouraged that relate to the synergistic mechanism of Alzheimer's disease with other dementia and neurodegenerative disorders. Book reviews, meeting reports and letters-to-the-editor are also published. The journal is essential reading for researchers, educators and physicians with interest in age-related dementia and Alzheimer’s disease. Current Alzheimer Research provides a comprehensive 'bird's-eye view' of the current state of Alzheimer's research for neuroscientists, clinicians, health science planners, granting, caregivers and families of this devastating disease.

Current Neuropharmacology aims to provide current, timely and comprehensive reviews and guest edited issues of all areas of neuropharmacology and related matters of neuroscience. The reviews cover the fields of molecular, cellular, and systems/behavioural aspects of neuropharmacology and neuroscience.

Current Neurovascular Research provides a cross platform for the publication of scientifically rigorous research that addresses disease mechanisms of both neuronal and vascular origins in neuroscience. The journal serves as an international forum publishing novel and original work as well as timely neuroscience research reviews in the disciplines of cell developmental disorders, plasticity, and degeneration that bridges the gap between basic science research and clinical discovery. Current Neurovascular Research emphasizes the elucidation of disease mechanisms, both cellular and molecular, which can impact the development of unique therapeutic strategies for neuronal and vascular disorders.

Current Opinion in Urology Online provides a powerful, broad-based perspective on the most important advances in the field from throughout the world literature. Reader-friendly, the journal features renowned guest editors focusing exclusively on two topics each issue. Bimonthly, every issue of Current Opinion in Urology delivers unvarnished, expert assessments of developments from the previous year. Insightful editorials and on-the-mark invited reviews cover key subjects such as benign prostatic hyperplasia; renal medicine and transplantation; functional reconstruction and trauma; oncology: bladder and testis; and pediatric urology--some 12 items in all of major relevance. All reviews are supplemented with an indispensable section, 'References and Recommended Reading'. At the back of each volume is 'Current World Literature', an exceptionally thorough bibliography culled from more than 100 top journals in the field.Website: www.co-urology.com.

The aim of this journal is to help the reader, by providing in a systematic manner, the views of experts on the current advances in the sexual health field in a clear and readable form and by providing reviews which highlight the most important papers recently published from the wealth of original publications. We accomplish this by appointing authorities in the following subject areas to select topics to be reviewed by leading experts in the field. ·         Male Sexual Dysfunction·         Female Sexual Dysfunction·         Current Controversies (in Sexual Health/Medicine)·         Sex Addiction and Compulsion·         Surgical Interventions·         Preclinical Trials and Psychophysiology·         Medical Comorbidities ·         Mental Health Aspects of Sex  Additionally, an international Editorial Board ensures that the journal content includes current, emerging research and suggests articles of special interest to their country or region.

‘Current Urology’ is an international peer-reviewed journal providing practical, timely, and state-of-the-art contributions on clinical research and experience in urology.

This journal intends to review the most important, recently published findings in the field of urology. By providing clear, insightful, balanced contributions by international experts, the journal elucidates current and emerging approaches to the care and prevention of urologic diseases and conditions.

We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as benign prostatic hyperplasia, erectile dysfunction, female urology, and kidney disease. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.

Zielsetzung der Zeitschrift
Der Urologe ist ein international angesehenes Publikationsorgan. Die Zeitschrift widmet sich allen Aspekten der Urologie und dient der Fortbildung von niedergelassenen und in der Klinik tätigen Urologen.
Im Vordergrund stehen Prävention, diagnostische Vorgehensweisen und Komplikationsmanagement sowie moderne Therapiestrategien.
Umfassende Übersichtsarbeiten zu einem aktuellen Schwerpunktthema sind das Kernstück jeder Ausgabe. Im Mittelpunkt steht dabei gesichertes Wissen zu Diagnostik und Therapie mit hoher Relevanz für die tägliche Arbeit – der Leser erhält konkrete Handlungsempfehlungen.
Frei eingereichte Originalien ermöglichen die Präsentation wichtiger klinischer Studien und dienen dem wissenschaftlichen Austausch.
Kasuistiken zeigen interessante Fallbeispiele und ungewöhnliche Krankheits- bzw. Behandlungsverläufe.
Beiträge der Rubrik „CME Zertifizierte Fortbildung“ bieten gesicherte Ergebnisse wissenschaftlicher Forschung und machen

El mejor medio de comunicación entre nefrólogos, inmunólogos, urólogos, cirujanos vasculares y profesionales de enfermería especializados en temas renales. Además es la Publicación Oficial de la Sociedad Española de Diálisis y Transplante y está incluida en prestigiosos índices de referencia médica.4 NÚMEROS AL AÑOPara más información, consulte http://www.elsevier.es/dialisis

Elsevier is the publisher of European Urology, the official journal of the European Association of Urology.European Urology publishes peer-reviewed original articles and topical reviews on a wide range of urological problems. Topics such as oncology, impotence, infertility, pediatrics, lithiasis and endourology, as well as recent advances in techniques, instrumentation, surgery and pediatric urology provide readers with a complete guide to international developments in urology.Published monthly, European Urology is an important journal for all clinicians and researchers in this field.All members of the EAU receive the journal as a benefit of their membership. For more information on the European Association of Urology, please go to: http://www.uroweb.orgSupplements to European Urology are published under the titleEuropean Urology Supplements (ISSN 1569-9056).All subscribers to European Urology automatically receive this publication.You can also visit the EAU-EBU Update Series (ISSN 1871-2592).

European Urology Focus is a new sister journal to European Urology and an official publication of the European Association of Urology (EAU).

EU Focus will publish original articles, opinion piece editorials and topical reviews on a wide range of urological issues such as oncology, functional urology, reconstructive urology, laparoscopy, robotic surgery, endourology, female urology, andrology, paediatric urology and sexual medicine. The editorial team welcome basic and translational research articles in the field of urological diseases. Authors may be solicited by the Editor directly. All submitted manuscripts will be peer-reviewed by a panel of experts before being considered for publication.

EU Focus will be published 6 times per year in an electronic format only. Each issue will include a series of invited, thematic reviews, together with original reports, correspondence and introductory editorials.

Supplements to European Urology are published under the title European Urology Supplements (ISSN 1569-9056). All subscribers to European Urology automatically receive this publication.European Urology Supplements is the perfect publication vehicle for the proceedings of a scientific symposium, commissioned thematic issues, or for disseminating a selection of invited articles.What makes European Urology Supplements unique is the fact that it has impact factor of 2.358 (2009)* and sits within the widely respected European Urology family of urology publications published by Elsevier on behalf of the EAU and EBU.Publication History: Incorporating EAU-EBU Update Series.You can also visit theEuropean Urology (ISSN 0302-2838) andEAU-EBU Update Series (ISSN 1570-9124).

Publishing original papers of scientific value in the field of Urology.